SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-20-030790
Filing Date
2020-10-09
Accepted
2020-10-09 16:06:35
Documents
1
Period of Report
2020-10-06

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ownership.html 4  
1 OWNERSHIP DOCUMENT ownership.xml 4 12059
  Complete submission text file 0001213900-20-030790.txt   13624
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Issuer) CIK: 0001506251 (see all company filings)

IRS No.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 11 COMMERCE DRIVE 11TH FLOOR CRANFORD NJ 07016
Business Address
Holuka Eugene Myron (Reporting) CIK: 0001678292 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38174 | Film No.: 201233271